SULAIMAN ALHABIB

Dr. Sulaiman Al-Habib Medical Services Group Co.

4013StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	13.71B	11.20B	9.51B	8.31B	7.25B
Cost of Revenue	9.51B	7.47B	6.25B	5.58B	4.93B
Gross Profit	4.19B	3.73B	3.25B	2.73B	2.32B
SG&A	1.57B	1.37B	1.16B	1.03B	0.85B
Operating Expenses	1.57B	1.37B	1.16B	1.03B	0.85B
Operating Income	2.62B	2.36B	2.10B	1.70B	1.47B
Interest Income	52.71M	56.76M	82.13M	40.72M	9.90M
Interest Expense	-338.80M	-162.76M	-70.11M	-49.36M	-37.90M
Other Income/Expense	163.64M	97.93M	40.14M	85.20M	55.70M
Pretax Income	2.52B	2.41B	2.17B	1.80B	1.50B
Income Tax	27.61M	42.90M	68.52M	107.71M	114.07M
Net Income	2.40B	2.32B	2.05B	1.65B	1.38B
EBITDA	3.19B	2.71B	2.36B	1.96B	1.73B
EBIT	2.62B	2.36B	2.10B	1.70B	1.47B
EPS (Basic)	6.86	6.62	5.85	4.72	3.93
EPS (Diluted)	6.86	6.62	5.85	4.72	3.93
DPS	—	4.77	4.32	3.48	2.80
Margins & Efficiency
Gross Margin %	+30.6%	+33.3%	+34.2%	+32.9%	+31.9%
EBITDA Margin %	+23.3%	+24.2%	+24.8%	+23.6%	+23.8%
Net Margin %	+17.5%	+20.7%	+21.5%	+19.9%	+19.0%
Revenue & Income
Revenue	13.71B	11.20B	9.51B	8.31B	7.25B
Revenue Growth (YoY)	+22.4%	+17.8%	+14.4%	+14.6%	+23.7%
Interest & Investment Income	52.71M	56.76M	82.13M	40.72M	9.90M
Earnings From Equity Investments	22.74M	20.99M	22.18M	19.61M	7.49M
Gain (Loss) on Sale of Investments	—	43.68M	—	—	—
Expenses & Provisions
Advertising Expenses	73.14M	42.05M	35.72M	32.82M	22.79M
Cost of Revenue	9.51B	7.47B	6.25B	5.58B	4.93B
Selling, General & Admin	1.57B	1.37B	1.16B	1.03B	0.85B
Operating Expenses	1.57B	1.37B	1.16B	1.03B	0.85B
Interest Expense	-338.80M	-162.76M	-70.11M	-49.36M	-37.90M
Other Non Operating Income (Expenses)	163.64M	97.93M	40.14M	85.20M	55.70M
D&A For EBITDA	573.95M	354.76M	262.57M	259.77M	262.11M
Profitability & Returns
Gross Profit	4.19B	3.73B	3.25B	2.73B	2.32B
Gross Margin	+30.6%	+33.3%	+34.2%	+32.9%	+31.9%
EBIT	2.62B	2.36B	2.10B	1.70B	1.47B
EBIT Margin	+19.1%	+21.0%	+22.0%	+20.5%	+20.2%
EBITDA	3.19B	2.71B	2.36B	1.96B	1.73B
EBITDA Margin	+23.3%	+24.2%	+24.8%	+23.6%	+23.8%
EBT Excluding Unusual Items	2.52B	2.37B	2.17B	1.80B	1.50B
Pretax Income	2.52B	2.41B	2.17B	1.80B	1.50B
Operating Income	2.62B	2.36B	2.10B	1.70B	1.47B
Operating Margin	+19.1%	+21.0%	+22.0%	+20.5%	+20.2%
Profit Margin	+17.5%	+20.7%	+21.5%	+19.9%	+19.0%
Net Income	2.40B	2.32B	2.05B	1.65B	1.38B
Net Income to Common	2.40B	2.32B	2.05B	1.65B	1.38B
Net Income Growth	+3.7%	+13.2%	+23.9%	+19.9%	+30.4%
Earnings From Continuing Ops.	2.49B	2.37B	2.10B	1.69B	1.39B
Minority Interest in Earnings	-90.19M	-54.67M	-55.46M	-38.20M	-10.66M
Income Tax Expense	27.61M	42.90M	68.52M	107.71M	114.07M
Effective Tax Rate	+1.1%	+1.8%	+3.2%	+6.0%	+7.6%
Per Share & Capital
EPS (Basic)	6.86	6.62	5.85	4.72	3.93
EPS (Diluted)	6.86	6.62	5.85	4.72	3.93
EPS Growth	+3.7%	+13.2%	+23.9%	+19.9%	+30.4%
Dividend Per Share	—	4.77	4.32	3.48	2.80
Shares Outstanding (Basic)	350.00M	350.00M	350.00M	350.00M	350.00M
Shares Outstanding (Diluted)	350.00M	350.00M	350.00M	350.00M	350.00M
Dividend Growth	—	+10.4%	+24.1%	+24.3%	+33.3%
Free Cash Flow	0.42B	-0.86B	-0.25B	1.33B	0.93B
Free Cash Flow Margin	+3.1%	-7.7%	-2.7%	+16.0%	+12.8%
Free Cash Flow Per Share	1.20	-2.45	-0.72	3.80	2.66
Payout Ratio	+69.2%	+70.9%	+70.1%	+68.9%	+68.6%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	13.71B	11.20B	9.51B	8.31B	7.25B
Cost of Revenue	9.51B	7.47B	6.25B	5.58B	4.93B
Gross Profit	4.19B	3.73B	3.25B	2.73B	2.32B
SG&A	1.57B	1.37B	1.16B	1.03B	0.85B
Operating Expenses	1.57B	1.37B	1.16B	1.03B	0.85B
Operating Income	2.62B	2.36B	2.10B	1.70B	1.47B
Interest Income	52.71M	56.76M	82.13M	40.72M	9.90M
Interest Expense	-338.80M	-162.76M	-70.11M	-49.36M	-37.90M
Other Income/Expense	163.64M	97.93M	40.14M	85.20M	55.70M
Pretax Income	2.52B	2.41B	2.17B	1.80B	1.50B
Income Tax	27.61M	42.90M	68.52M	107.71M	114.07M
Net Income	2.40B	2.32B	2.05B	1.65B	1.38B
EBITDA	3.19B	2.71B	2.36B	1.96B	1.73B
EBIT	2.62B	2.36B	2.10B	1.70B	1.47B
EPS (Basic)	6.86	6.62	5.85	4.72	3.93
EPS (Diluted)	6.86	6.62	5.85	4.72	3.93
DPS	—	4.77	4.32	3.48	2.80
Margins & Efficiency
Gross Margin %	+30.6%	+33.3%	+34.2%	+32.9%	+31.9%
EBITDA Margin %	+23.3%	+24.2%	+24.8%	+23.6%	+23.8%
Net Margin %	+17.5%	+20.7%	+21.5%	+19.9%	+19.0%
Revenue & Income
Revenue	13.71B	11.20B	9.51B	8.31B	7.25B
Revenue Growth (YoY)	+22.4%	+17.8%	+14.4%	+14.6%	+23.7%
Interest & Investment Income	52.71M	56.76M	82.13M	40.72M	9.90M
Earnings From Equity Investments	22.74M	20.99M	22.18M	19.61M	7.49M
Gain (Loss) on Sale of Investments	—	43.68M	—	—	—
Expenses & Provisions
Advertising Expenses	73.14M	42.05M	35.72M	32.82M	22.79M
Cost of Revenue	9.51B	7.47B	6.25B	5.58B	4.93B
Selling, General & Admin	1.57B	1.37B	1.16B	1.03B	0.85B
Operating Expenses	1.57B	1.37B	1.16B	1.03B	0.85B
Interest Expense	-338.80M	-162.76M	-70.11M	-49.36M	-37.90M
Other Non Operating Income (Expenses)	163.64M	97.93M	40.14M	85.20M	55.70M
D&A For EBITDA	573.95M	354.76M	262.57M	259.77M	262.11M
Profitability & Returns
Gross Profit	4.19B	3.73B	3.25B	2.73B	2.32B
Gross Margin	+30.6%	+33.3%	+34.2%	+32.9%	+31.9%
EBIT	2.62B	2.36B	2.10B	1.70B	1.47B
EBIT Margin	+19.1%	+21.0%	+22.0%	+20.5%	+20.2%
EBITDA	3.19B	2.71B	2.36B	1.96B	1.73B
EBITDA Margin	+23.3%	+24.2%	+24.8%	+23.6%	+23.8%
EBT Excluding Unusual Items	2.52B	2.37B	2.17B	1.80B	1.50B
Pretax Income	2.52B	2.41B	2.17B	1.80B	1.50B
Operating Income	2.62B	2.36B	2.10B	1.70B	1.47B
Operating Margin	+19.1%	+21.0%	+22.0%	+20.5%	+20.2%
Profit Margin	+17.5%	+20.7%	+21.5%	+19.9%	+19.0%
Net Income	2.40B	2.32B	2.05B	1.65B	1.38B
Net Income to Common	2.40B	2.32B	2.05B	1.65B	1.38B
Net Income Growth	+3.7%	+13.2%	+23.9%	+19.9%	+30.4%
Earnings From Continuing Ops.	2.49B	2.37B	2.10B	1.69B	1.39B
Minority Interest in Earnings	-90.19M	-54.67M	-55.46M	-38.20M	-10.66M
Income Tax Expense	27.61M	42.90M	68.52M	107.71M	114.07M
Effective Tax Rate	+1.1%	+1.8%	+3.2%	+6.0%	+7.6%
Per Share & Capital
EPS (Basic)	6.86	6.62	5.85	4.72	3.93
EPS (Diluted)	6.86	6.62	5.85	4.72	3.93
EPS Growth	+3.7%	+13.2%	+23.9%	+19.9%	+30.4%
Dividend Per Share	—	4.77	4.32	3.48	2.80
Shares Outstanding (Basic)	350.00M	350.00M	350.00M	350.00M	350.00M
Shares Outstanding (Diluted)	350.00M	350.00M	350.00M	350.00M	350.00M
Dividend Growth	—	+10.4%	+24.1%	+24.3%	+33.3%
Free Cash Flow	0.42B	-0.86B	-0.25B	1.33B	0.93B
Free Cash Flow Margin	+3.1%	-7.7%	-2.7%	+16.0%	+12.8%
Free Cash Flow Per Share	1.20	-2.45	-0.72	3.80	2.66
Payout Ratio	+69.2%	+70.9%	+70.1%	+68.9%	+68.6%